← Leaderboards
Christina L Costantino
Massachusetts General Hospital
$131,200
Attributed
$131,200
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $67.5K · FY2017–18$100K$75K$50K$25K$0
'17
'18
Funding mix
By agency
NIH$131,200 · 1
By mechanism
F32$131,200 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Mehmet Toner$56,861,630
- Daniel A. Haber$29,412,047
- Aaron N Hata$5,868,906
- Daniel Irimia$10,350,962
- Jeffrey A Engelman$5,049,484
Others in their field
Other Emerging Leaders on “Actionable Mutation”
- Erin Rooney Riggs · Broad Institute, Inc.$6,471,349
- Steven Armen Boyd · Venatorx Pharmaceuticals, Inc.$6,328,779
- Thomas Dick · Rbhs-New Jersey Medical School$5,970,903
- Brian Liau · Harvard University$4,574,123
- Christine Ladd-Acosta · Johns Hopkins University$4,560,160
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$4,505,832
Research focus
Actionable MutationAdvanced DiseaseAnimalsAnticancer ResearchBaseBehaviorBloodBlood CellsBlood CirculationBreastCancer Cell LineCancer DiagnosisCancer EtiologyCancer ModelCancer PatientCell LineCellsCessation Of LifeChemotherapy-Oncologic ProcedureClinical ApplicationClinical ResearchCombined Modality TherapyCurative TreatmentsAcquired Drug Resistance